Semaglutide does not appear to cause infertility. For many women with obesity or PCOS, weight loss on the drug may make conception more likely, which is why some people become pregnant unexpectedly while taking it. The catch is timing: the FDA labeling for semaglutide products advises stopping at least 2 months before a planned pregnancy, and the drug should not be continued once you are pregnant. This guide covers what we know, what we don’t, and how to plan.
TL;DR
- There is no definitive evidence that semaglutide causes infertility. In women with PCOS, it may help restore ovulation and regular cycles.
- Plan to stop semaglutide at least 2 months (about 8 weeks) before trying to conceive, and stop right away if you get a positive pregnancy test.
- Because semaglutide slows stomach emptying, oral contraceptive pills may work less reliably. Ask your prescriber about a non-oral method such as an IUD or implant.
- Weight loss before pregnancy can help, but weight loss during pregnancy is not safe. That is the core reason the drug is stopped.
- Men are part of this question too, and early data on sperm health looks reassuring but is limited.
Table of Contents
- Why people ask about semaglutide and fertility
- Does semaglutide make it harder to get pregnant?
- Semaglutide, PCOS and ovulation
- The 2-month washout before you try to conceive
- Birth control while you are on semaglutide
- What if you get pregnant on semaglutide?
- Semaglutide and male fertility
- Other questions to settle before you conceive
- Our perspective
- Getting a prescriber’s guidance on semaglutide
- FAQ
- Sources
Why people ask about semaglutide and fertility
Two things are true at once, and they confuse people. First, excess weight can make it harder to conceive. Second, semaglutide is not approved for use in pregnancy. Online forums are full of stories of women who started a GLP-1 medication, lost weight, and then found out they were pregnant. Those stories are real, but they are anecdotes, not proof of cause and effect.
What clinicians can say with more confidence comes from the research. A 2025 narrative review on medical therapy for obesity and fertility concluded that meaningful weight loss with medication is achievable in women of reproductive age and may help enhance fertility. A 2026 review of GLP-1 receptor agonists and fertility describes the drugs as a potential adjunct in preconception care for women with PCOS and infertility, while noting that the evidence is still developing.
So the honest summary is: the drug is not a fertility treatment, it is not known to damage fertility, and it can change your body in ways that affect your chances of conceiving.
Does semaglutide make it harder to get pregnant?
No good evidence says it does. The common belief that GLP-1 medications cause infertility is a misconception, according to the same 2026 review. Emerging evidence points the other way for many people: by improving insulin sensitivity and hormonal balance, these drugs can restore ovulation and cycle regularity, which may raise the chance of spontaneous pregnancy in PCOS-related infertility.
A few caveats matter:
- Most of the data comes from small or short studies, often in women with PCOS. It does not tell us what happens in every body.
- Rapid weight loss, reduced eating and nausea can temporarily disrupt menstrual cycles in some people, whatever drug is involved. A late period on semaglutide is not automatically a sign of pregnancy or of a fertility problem, but it is worth a test and a conversation with your prescriber.
- No study should be read as a promise that you will conceive.
Semaglutide, PCOS and ovulation
Polycystic ovary syndrome is one of the most common causes of ovulation problems, and insulin resistance sits at the center of it for many patients. That is why PCOS is where most of the fertility research on semaglutide has focused.
The clearest recent data is a randomized controlled trial published in July 2025 in overweight or obese women with PCOS. It compared metformin alone with metformin plus semaglutide. In the follow-up window of 24 weeks after semaglutide was stopped, the natural pregnancy rate was 35% in the combination group versus 15% with metformin alone. In the portion of the study reported as 80 participants, the semaglutide group lost an average of 6.09 kg over 16 weeks, compared with 2.25 kg on metformin alone.
What this does and does not show:
| What the trial suggests | What it does not show |
|---|---|
| Adding semaglutide to metformin can improve weight and metabolic markers in PCOS | That semaglutide is a stand-alone fertility drug |
| Pregnancy rates after a planned course followed by stopping the drug were higher | That the result applies to people without PCOS or at a normal weight |
| Stopping the drug before conception was built into the design | That it is safe to keep taking it while trying to conceive |
If you are curious about how the two drugs are often combined in practice, our guide to semaglutide with metformin walks through the evidence and safety steps.
The “metabolic optimization” idea
The expert consensus described in the 2025 narrative review is that GLP-1 receptor agonists can serve as a bridge. The goal is to reach a healthier weight and metabolic profile, improve insulin sensitivity and cycle regularity, and then transition off the medication in a planned way so that pregnancy starts in a nutrient-rich, stable state. The drug is a means to a better starting point, not something you carry into pregnancy.
The 2-month washout before you try to conceive
Semaglutide has a long half-life, which is why a washout period exists. The current FDA labeling advises that people of reproductive potential discontinue the medication at least 2 months before a planned pregnancy. A clinical systematic review of GLP-1 safety around pregnancy likewise stresses a washout of at least 8 to 10 weeks so the drug is fully cleared, reducing theoretical fetal risks seen in animal studies.
The MotherToBaby fact sheet on semaglutide is a good plain-language reference if you want to read how clearance time is explained for patients.
A practical timeline many prescribers use looks like this:
- Four to six months out: Tell your prescriber you want to conceive. Review your dose, your weight goal and any other medications.
- At least 2 months before trying: Take your last dose. Keep tracking your cycles.
- During the washout: Use reliable contraception, then switch to trying when the washout is complete and your prescriber agrees.
- Start prenatal care: Begin a prenatal vitamin and schedule a preconception visit with your OB-GYN.
This is a general outline, not a prescription for you. Your dose, your history and your other conditions change the plan.
What happens to your weight when you stop
Stopping a GLP-1 medication often brings back appetite, and some regain is common. That is not a reason to delay the washout, but it is a reason to plan. Our guide on limiting regain after stopping semaglutide lays out a 12-week prescriber plan. For pregnancy, the goal shifts: you are no longer trying to lose weight, so nutrition guidance from your OB-GYN or a registered dietitian takes over.
Birth control while you are on semaglutide
This is the part people most often miss. Semaglutide delays gastric emptying, and the FDA label for Wegovy notes this can affect the absorption of oral medications taken at the same time. A review of GLP-1 drugs and fertility notes that clinicians often recommend non-oral, long-acting options such as an IUD or implant for sexually active patients, since an oral contraceptive may be less effective in this period.
There is an added wrinkle. If weight loss or PCOS treatment restores your ovulation, you can become fertile again quickly, sometimes before you expect it. If you do not want to be pregnant, do not count on irregular cycles as protection.
Our article on GLP-1 and birth control goes deeper on which methods make sense. Talk with your prescriber or gynecologist before you change anything.
What if you get pregnant on semaglutide?
Stop the medication and contact your OB-GYN or prescriber the same day. Do not wait for your next scheduled dose or appointment.
Try to keep the risk in perspective. According to MotherToBaby, studies including more than 4,000 women exposed to GLP-1 medications during the first trimester have not shown an increased chance of birth defects or miscarriage. Their semaglutide fact sheet puts the background rates at around 3% for birth defects and 15% to 20% for miscarriage, which occur in any pregnancy.
The reason for stopping is still firm. According to the 2026 systematic review, the main concern is not a proven toxic effect in human fetuses. It is the lack of safety data across the second and third trimesters, combined with the harm that intentional weight loss and appetite suppression could cause during pregnancy. A growing fetus needs adequate nutrition, and semaglutide works by reducing appetite. The FDA label also describes a pregnancy exposure registry for people exposed to semaglutide during pregnancy, which your provider can help you join.
If you have diabetes, do not simply stop all treatment on your own. Blood sugar control during pregnancy matters, and your prescriber or OB-GYN will help you move to a regimen that is appropriate.
Semaglutide and male fertility
Fertility is not only a female question. Some social media posts cite a study where semaglutide preserved or modestly improved sperm concentration while testosterone replacement lowered it. That finding comes from early research, and we would treat it as a promising signal rather than established fact. Obesity itself is associated with changes in male hormones, so weight loss may help, but men planning a pregnancy with a partner should ask their prescriber about timing. The FDA label’s guidance on stopping before a planned pregnancy applies to males and females of reproductive potential alike.
Other questions to settle before you conceive
Breastfeeding. If you are planning to use semaglutide after delivery, review the data first. We summarize it in our article on semaglutide and breastfeeding.
Compounded versions. Safety and effects on fertility are not established for products of uncertain quality. If you are deciding between sources, read our guide to compounded semaglutide safety.
Thyroid concerns. Some patients ask about family history before starting. Our piece on semaglutide and thyroid cancer risk explains the boxed warning in plain language.
Semaglutide or tirzepatide. Tirzepatide is a dual GLP-1/GIP drug, and it carries similar planning issues for pregnancy, including the oral contraceptive question. If you are comparing the two, see semaglutide vs tirzepatide.
Our perspective
We see two mistakes again and again. The first is fear: people assume a GLP-1 medication will damage their fertility and refuse a treatment that could improve their health. The evidence does not support that fear. The second is surprise: people assume that because they struggled to conceive before, they cannot get pregnant now, skip reliable contraception, and learn about the washout rule from a positive test.
Our approach is to treat pregnancy intentions as part of the medical conversation from day one. When someone completes intake with us, the provider assessment is the place to say “I might want a baby in the next year” or “I’m not sure.” That one sentence changes the plan: the dose we aim for, the timeline for stopping, and the contraception we discuss. Support after the visit matters just as much, because the questions come later, usually at 10 p.m. when a period is late.
We also think it is worth saying plainly what a medication cannot do. Semaglutide can help you reach a healthier starting point. It cannot guarantee a pregnancy, and it should never travel with you into one. If fertility is your main goal, a reproductive endocrinologist or your OB-GYN should be on your team alongside your prescriber.
— Bryan
Getting a prescriber’s guidance on semaglutide
If you are considering weight loss treatment and a future pregnancy is on your mind, start with a medical assessment that takes your plans into account. Legacy Meds offers an online program with a provider assessment, free shipping and unlimited coaching support, with no insurance and no membership fees. Our semaglutide program starts from $159 per month, and GLP-1 injections start from $159. You can see all options, including GLP-1 tablets from $249, on the Legacy Meds site. Mention your pregnancy plans during intake so your provider can build the timeline around them.
FAQ
Does semaglutide make it harder to get pregnant?
There is no definitive evidence that it does. In women with PCOS, the research points to improved ovulation and cycle regularity, which may make pregnancy more likely. Any change in your cycle is worth discussing with your prescriber.
Has anyone gotten pregnant while on Ozempic or Wegovy?
Yes, and it is widely reported, though case stories are not controlled research. Weight loss can restore ovulation, and semaglutide may reduce the effectiveness of oral contraceptive pills. If this happens, stop the medication and call your OB-GYN or prescriber right away.
How long before trying to conceive should I stop semaglutide?
The FDA labeling advises stopping at least 2 months before a planned pregnancy because of the drug’s long half-life. Some clinicians suggest 8 to 10 weeks. Your prescriber can set the exact date based on your dose.
What should I do if I accidentally get pregnant on semaglutide?
Stop taking it and contact your OB-GYN or prescriber the same day. Studies of more than 4,000 women exposed in the first trimester have not shown higher rates of birth defects or miscarriage, but monitoring and nutrition support still matter.
Can I use birth control pills while taking semaglutide?
They may be less reliable, because semaglutide slows stomach emptying and can affect absorption of oral medications. Many clinicians recommend an IUD, implant or barrier method instead. Ask your prescriber or gynecologist which fits you.
Sources
- FDA prescribing information for semaglutide, 2026
- FDA Wegovy label, 2021
- Metformin plus semaglutide in women with PCOS, randomized trial, 2025
- MotherToBaby: Semaglutide fact sheet
- MotherToBaby: How GLP-1s fit into your pregnancy plans
- Safety of GLP-1 and dual GLP-1/GIP agonists in preconception, pregnancy and lactation: systematic review
- GLP-1 receptor agonists and fertility: what is known so far
- Medical therapy to treat obesity and optimize fertility: narrative review